MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change

    I. Piot, K. Schweyer, G. Respondek, M. Grimm, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, G. Stebbins, G. Höglinger (Munich, Germany)

    Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…
  • 2019 International Congress

    Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies

    G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)

    Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…
  • 2019 International Congress

    Stereopsis as a Visual Biomarker for Parkinson’s Disease

    T. Sang, J. Fatehi, E. Mostofi, B. Zheng, F. Ba (Edmonton, AB, Canada)

    Objective: 1): To assess Parkinson’s disease (PD) patients’ stereopsis function using better and more physiologically meaningful tools; 2): To reveal specific eye behaviors of stereoacuity…
  • 2019 International Congress

    Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, M. Brumm, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Chicago, IL, USA)

    Objective: To compare baseline clinical and imaging characteristics of the GBA and LRRK2 PD manifest cohorts to PD sporadic (sPD) cohort. Background: The phenotype and…
  • 2019 International Congress

    Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS

    T. Stiep, D. Spengler Shpiner, C. Luca (Miami, FL, USA)

    Objective: To present a case of Parkinson’s disease (PD) complicated by impulse control disorder (ICD) which improved following deep brain stimulation (DBS) targeting the bilateral…
  • 2019 International Congress

    Impact of a high-fat diet on the behavior of A53T alpha-Synuclein Parkinson’s disease mice

    M. Temmel, V. Niederkofler, R. Rabl, H. Roemer, B. Hutter-Paier (Grambach, Austria)

    Objective: The aim of this project was to evaluate high-fat diet (HFD) induced behavioral alterations in the A53T alpha-Synuclein Parkinsons’s disease mouse model. Background: Besides…
  • 2019 International Congress

    MRI cortical layer study in patients with Parkinson’s disease in Uzbekistan

    A. Umarov, D. Tolibov (Tashkent, Uzbekistan)

    Objective: We aimed to establish, using MRI, the presence of differences in the thickness of the cortical layers in patients with early and developed stages…
  • 2019 International Congress

    Heterogeneous patterns of striatal dopamine loss in patients with young- versus old-onset Parkinson’s disease

    NE. Woo, SJ. Chung, HS. Yoo, YH. Lee, PH. Lee, YH. Sohn (Seoul, Republic of Korea)

    Objective: Patients with Parkinson's disease have different patterns of stiratal dopamine loss by age onf onset. Background: Ample evidence has suggested that age at onset…
  • 2019 International Congress

    Discriminative power of different olfactory domains in Parkinson’s disease

    YW. Zhao, RC. He, JX. Yang, Y. Zhang, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate which kind of olfactory domain was the best in discriminating PD patients from controls, and to…
  • 2019 International Congress

    The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

    M. Kurian, V. Leuzzi, K. Peall, R. Pons, R. Dale, E. de Grandis, S. Yilmaz, J. Cobben, R. Guerrini, E. Sheridan, P. Vieira, J. Uusimaa, P. Munot, F. Muntoni, M. Smith, S. Mohammed, E. Meyer, J. Ng, A. Papandreou, H. Baide, F. Danti, A. Macaya, J. Ortigoza, K. Gorman, B. Perez Duenas (Barcelona, Spain)

    Objective: To better delineate the genetic landscape and key clinical characteristics that define complex early onset monogenic hyperkinetic movement disorders (HMD). Background: Hyperkinetic movement disorders…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley